Logo image of ONC

BEONE MEDICINES LTD-ADR (ONC) Stock Analyst Earnings Estimates

NASDAQ:ONC - Nasdaq - US07725L1026 - ADR - Currency: USD

288.18  -10.11 (-3.39%)

After market: 288.18 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
ONC revenue by date.ONC revenue by date.
9.566B
26.06%
17.423B
82.13%
27.214B
56.19%
36.776B
35.14%
44.542B
21.12%
51.341B
15.26%
57.132B
11.28%
63.277B
10.76%
69.958B
10.56%
73.656B
5.29%
75.662B
2.72%
EBITDA
YoY % growth
ONC ebitda by date.ONC ebitda by date.
N/A
-38.91%
N/A
26.94%
N/A
56.75%
1.743B
150.24%
4.889B
180.49%
8.93B
82.65%
18.695B
109.35%
25.374B
35.73%
37.191B
46.57%
42.695B
14.80%
N/A
EBIT
YoY % growth
ONC ebit by date.ONC ebit by date.
-12.026B
-27.00%
-8.751B
27.23%
-4.242B
51.53%
449.4M
110.59%
3.664B
715.31%
6.557B
78.96%
13.2B
101.31%
16.497B
24.98%
21.112B
27.97%
24.972B
18.28%
26.534B
6.26%
Operating Margin
ONC operating margin by date.ONC operating margin by date.
-125.71%-50.22%-15.59%1.22%8.23%12.77%23.10%26.07%30.18%33.90%35.07%
EPS
YoY % growth
ONC eps by date.ONC eps by date.
-127.00
45.69%
-57.86
54.44%
-45.41
21.52%
4.34
109.55%
32.17
641.69%
65.38
103.25%
1,447.88
2,114.39%
2,207.79
52.48%
2,936.80
33.02%
1,929.79
-34.29%
2,514.09
30.28%

All data in CNY

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q3 / 25
EPS
Q2Q % growth
0.63
107.83%
Revenue
Q2Q % growth
9.338B
30.12%
EBITDA
Q2Q % growth
N/A
EBIT
Q2Q % growth
81.276M
109.49%

All data in CNY

Recent Earnings VS Estimates Surprises (CNY)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
75.33
172.51%
0.3874.9519,828.24%
Q1 2025
Q2Q % growth
109.98
150.90%
-3.65113.633,109.85%
Q4 2024
Q2Q % growth
282.57
1,260.99%
14.87267.701,800.57%
Q3 2024
Q2Q % growth
-8.05
-159.34%
-6.55-1.49-22.81%
Q2 2024
Q2Q % growth
-103.88
-323.98%
-11.47-92.41-805.99%
Q1 2024
Q2Q % growth
-216.05
-856.85%
-19.66-196.40-999.20%
Q4 2023
Q2Q % growth
-24.34
18.03%
-10.33-14.01-135.57%
Q3 2023
Q2Q % growth
13.56
138.68%
-23.6937.25157.25%
Q2 2023
Q2Q % growth
-24.50
30.85%
-22.68-1.82-8.03%
Q1 2023
Q2Q % growth
-22.58
15.81%
-22.30-0.28-1.25%
Q4 2022
Q2Q % growth
-29.69
25.20%
-11.84-17.85-150.68%
Q3 2022
Q2Q % growth
-35.05 -35.150.100.28%
Q2 2022
Q2Q % growth
-35.43 -27.72-7.71-27.81%
Q1 2022
Q2Q % growth
-26.82 -23.81-3.01-12.63%
Q4 2021
Q2Q % growth
-39.70 -31.75-7.94-25.02%
ONC Yearly EPS VS EstimatesONC Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 1K 2K
Recent Revenue VS Estimates Surprises (CNY)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
9.455B
40.53%
8.91B544.903M6.12%
Q1 2025
Q2Q % growth
8.074B
50.65%
8.176B-102.423M-1.25%
Q4 2024
Q2Q % growth
7.908B
73.88%
7.496B412.084M5.50%
Q3 2024
Q2Q % growth
7.176B
27.60%
7.158B18.363M0.26%
Q2 2024
Q2Q % growth
6.728B
60.77%
5.255B1.473B28.03%
Q1 2024
Q2Q % growth
5.359B
74.78%
4.557B802.338M17.61%
Q4 2023
Q2Q % growth
4.548B
68.60%
4.07B478.108M11.75%
Q3 2023
Q2Q % growth
5.624B
111.55%
4.108B1.516B36.90%
Q2 2023
Q2Q % growth
4.185B
84.97%
3.256B928.839M28.53%
Q1 2023
Q2Q % growth
3.066B
57.42%
2.897B169.389M5.85%
Q4 2022
Q2Q % growth
2.698B
98.00%
2.44B257.639M10.56%
Q3 2022
Q2Q % growth
2.659B
99.05%
2.406B252.516M10.50%
Q2 2022
Q2Q % growth
2.262B
135.16%
2.048B214.396M10.47%
Q1 2022
Q2Q % growth
1.948B
-50.42%
1.838B109.858M5.98%
Q4 2021
Q2Q % growth
1.362B
105.94%
1.413B-50.562M-3.58%
Q3 2021
Q2Q % growth
1.336B
-8.44%
%
ONC Yearly Revenue VS EstimatesONC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 20B 40B 60B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -70.97% 0% -3.22%
Revenue0% -0.07% -0.41% -0.41%